Chamber Particle PCR for Droplet-Free Nucleic Acid Amplification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Digital droplet PCR systems are complex and costly due to the need for droplet generation, which complicates the overall assay process.
Innovation Solution
The use of solid, distributed chamber particles for nucleic acid amplification bypasses droplet generation, allowing for simplified integration with Thermal Inkjet microfluidics and pre-treatment of reagents within the chamber particles.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If digital droplet PCR is used for nucleic acid amplification, then quantitative analysis precision is improved, but device complexity and cost increase due to droplet generation requirements
Solution Approach 1:
The invention divides the amplification system into discrete chamber particles, each containing a separate reaction chamber. This segmentation eliminates the need for complex droplet generation machinery while maintaining the ability to perform individual amplification reactions in isolation, thus reducing device complexity while preserving quantitative analysis precision through digital counting of positive chambers.
Solution Approach 2:
The invention uses solid chamber particles as simplified copies or alternatives to liquid droplets. These chamber particles replicate the functional capability of droplets (containing reagents and template DNA for amplification) without requiring the complex generation and manipulation machinery needed for droplet-based systems, thereby reducing device complexity while maintaining measurement precision.
2Manufacturing precision
If droplet generation is implemented in digital droplet PCR, then amplification accuracy is improved, but manufacturing cost and assay complexity increase
Solution Approach 1:
The chamber particles are pre-loaded with amplification reagents (polymerase, dNTPs, primers, and buffer) during their manufacturing process. This preliminary action eliminates the need for complex post-manufacturing reagent distribution steps and simplifies the overall assay protocol, reducing manufacturing complexity while maintaining amplification accuracy through consistent reagent provision in each chamber.
3Device complexity
If solid chamber particles are used instead of droplets, then device complexity is reduced, but integration with microfluidics becomes simpler
Solution Approach 1:
The invention merges the chamber particle structure with microfluidic channel geometry, allowing the particles to be directly manipulated and transported through microfluidic devices. This merging simplifies the overall system by combining the amplification chamber function with the fluid handling capability, reducing device complexity while enhancing adaptability to microfluidic integration for automated sample processing and analysis.
Data Source
Figure 1A~1B
Figure 2A~2C
Figure 3~4
AI summary
Examples relate to techniques for performing a nucleic acid amplification reaction. The method includes generating a nucleic acid solution comprising a plurality of nucleic acid molecules, and combining the nucleic acid solution with a plurality of chamber particles. Each chamber particle includes a chamber for receiving the nucleic acid solution, wherein the chamber receives, at most, one of the plurality of nucleic acid molecules. Each chamber particle also includes reagents for causing a polymerase chain reaction within the chamber. The method further includes inducing nucleic acid amplification to generate an amplified nucleic acid, and performing a detection process to detect the presence of the amplified nucleic acid within the chamber.